Skip to content
Screener

Gyre Therapeutics, Inc. GYRE Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

Cato Corporation logo
Cato CorporationCATO
$1.07M+4.7%
3M logo
3MMMM
$223M+7.2%
MillerKnoll logo
MillerKnollMLKN
$38.9M-1.5%
GE Vernova logo
GE VernovaGEV
$377M+126%
Healthcare Services Group logo
Healthcare Services GroupHCSG
$1.63M+23.4%
AIR
Air TAIRT
$15.26M+10,139%

Segments

By segment

See full
Gyre Pharmaceuticals$208K-18.8%
Gyre$54K-31.6%
All Other Segments$0—

Other financials

Income statement

See full
Revenue$29.1M-2.1%
Gross profit$26.9M-5.9%
Operating income-$14.4M-541%
Net income-$11.7M-471%
EPS (diluted)-$0.12-300%

Balance sheet

See full
Cash & equivalents$43.3M+18.6%
Total debt$3.4M+145%
Total equity$107.9M+17.3%
Total assets$199.3M+30.5%

Cash flow

See full
Operating cash flow-$16.7M-124%
CapEx$262.0K-21.8%
Free cash flow-$17.0M-118%

Valuation

See full
Market cap$712.55M+11.2%
Enterprise value$672.68M+11.0%
P/S6×-0.1×

Profitability

See full
Gross margin94.3%-1.7pp
Operating margin-14%-18.7pp
Net margin-13.4%-15.1pp
FCF margin-5.1%—

Returns & leverage

See full
Return on equity-16%-18.3pp
Debt / equity0×0.0×
Current ratio4.3×-1.1×